| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |